A novel primeboost immunotherapy induces high levels of HBeAg loss after 14 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIA clinical trial

Halota, W.; Delić, Dragan; Nešić, Zorica; Prokopowicz, D.; Flisiak, R.; Kuydowicz, I.; Jablkowski, I.; Cianciara, J.; Mach, T.; Modrzewska, R.; Fabri, Miklos; Sad, N.; Tomić, Dragan; Horban, A.; Kryczka, W.; Schneider, J.; Pearce, G.

Results

eNauka > Results > A novel primeboost immunotherapy induces high levels of HBeAg loss after 14 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIA clinical trial

Title:	A novel primeboost immunotherapy induces high levels of HBeAg loss after 14 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIA clinical trial
Authors:	Halota, W.; Delić, Dragan; Nešić, Zorica ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, I.; Jablkowski, I.; Cianciara, J.; Mach, T.; Modrzewska, R.; Fabri, Miklos; Sad, N.; Tomić, Dragan; Horban, A.; Kryczka, W.; Schneider, J.; Pearce, G.;
Issue Date:	2005
Publication:	Hepatology
ISSN:	0270-9139 Hepatology Search Idenfier
Publisher:	Baltimore, M.D. : Williams & Wilkins
Type:	Conference Paper
Collation:	vol. 42 br. issue 4 str. 269A-270A
WoS-ID:	000232480300183
VBS COBISS:	1026927541
URI:	https://plus.cobiss.net/cobiss/sr/sr/bib/1026927541#izum.si https://enauka.gov.rs/handle/123456789/645597
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM